[123I]NAV5001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for [123I]NAV5001, covering 2017-09-13 to 2018-10-05. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes [Phase 3]